Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Participants in Oregon’s state-regulated psilocybin program reported improvements in depression, anxiety, PTSD symptoms, mental well-being, and life satisfaction over 3 months.
Participants in Oregon’s state-regulated psilocybin program reported improvements in depression, anxiety, PTSD symptoms, mental well-being, and life satisfaction over 3 months.
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
In a preregistered study of 106 adults, individuals with major depressive disorder (MDD) reported more mind-wandering than healthy controls during a continuous performance task.
In a preregistered study of 106 adults, individuals with major depressive disorder (MDD) reported more mind-wandering than healthy controls during a continuous performance task.
Baseline alcohol, nicotine, and cannabis use was largely not associated with antidepressant response to rTMS among patients with MDD, according to study findings.
Baseline alcohol, nicotine, and cannabis use was largely not associated with antidepressant response to rTMS among patients with MDD, according to study findings.
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
Patients with TRD receiving repeated, low-dose oral esketamine did not experience greater increases in serum BDNF than those receiving placebo, according to study findings.
Patients with TRD receiving repeated, low-dose oral esketamine did not experience greater increases in serum BDNF than those receiving placebo, according to study findings.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.